Correlation Between Cingulate Warrants and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and SAB Biotherapeutics, you can compare the effects of market volatilities on Cingulate Warrants and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and SAB Biotherapeutics.
Diversification Opportunities for Cingulate Warrants and SAB Biotherapeutics
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cingulate and SAB is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and SAB Biotherapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 1.0 times more return on investment than SAB Biotherapeutics. However, Cingulate Warrants is 1.0 times more volatile than SAB Biotherapeutics. It trades about 0.12 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.11 per unit of risk. If you would invest 20.00 in Cingulate Warrants on August 24, 2024 and sell it today you would lose (15.87) from holding Cingulate Warrants or give up 79.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 97.86% |
| Values | Daily Returns |
Cingulate Warrants vs. SAB Biotherapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| SAB Biotherapeutics |
Cingulate Warrants and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and SAB Biotherapeutics
The main advantage of trading using opposite Cingulate Warrants and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Cingulate Warrants vs. Lyra Therapeutics | Cingulate Warrants vs. Hookipa Pharma | Cingulate Warrants vs. SAB Biotherapeutics | Cingulate Warrants vs. Cadrenal Therapeutics, Common |
| SAB Biotherapeutics vs. Lyra Therapeutics | SAB Biotherapeutics vs. Hookipa Pharma | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |